Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort

Sa1256 Cost-Effectiveness of Episodic or Maintenance Infliximab Treatment Versus Standard Treatment in a Community-Based Incidence Cohort of Adult Ulcerative Colitis Patients With 10-Years Follow-up

(2015) Selwyn H. Odes et al.   GASTROENTEROLOGY

Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease — An ECCO-EpiCom study☆

(2014) J. Burisch et al.   Journal of Crohns & Colitis

Burden of Disease: Psoriasis and Psoriatic Arthritis

(2013) Wolf-Henning Boehncke et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

(2013) J Burisch et al.   GUT

Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe

(2013) Johan Burisch et al.   INFLAMMATORY BOWEL DISEASES

The burden of inflammatory bowel disease in Europe

(2013) Johan Burisch et al.   Journal of Crohns & Colitis

Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977–2009

(2012) Peter Laszlo Lakatos et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

(2012) Mirthe Emilie van der Valk et al.   GUT

P254 Effect of standard treatment (ST) versus episodic (ET) or maintenance (MT) infliximab on healthcare cost (HC) and quality-adjusted life years (QALYs) in a community-based incidence cohort of adult Crohn's disease patients with 10 years follow-up

(2012) S. Odes et al.   Journal of Crohns & Colitis

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Guidelines for the management of inflammatory bowel disease in adults

(2011) C. Mowat et al.   GUT

Cancer in inflammatory bowel disease 15years after diagnosis in a population-based European Collaborative follow-up study

(2011) Konstantinos H. Katsanos et al.   Journal of Crohns & Colitis

Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe

(2011) Johan Burisch et al.   Journal of Crohns & Colitis

Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease

(2011) Gord Blackhouse et al.   Journal of Crohns & Colitis

Costs of care for Crohn’s disease following the introduction of infliximab: a single-centre UK experience

(2010) M. B. Sprakes et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: the costs of ulcerative colitis in Western countries

(2010) R. D. COHEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

(2010) Gert Van Assche et al.   Journal of Crohns & Colitis

Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method

(2010) Betty Tao et al.   PLoS One

Annual Medical Spending Attributable To Obesity: Payer-And Service-Specific Estimates

(2009) Eric A. Finkelstein et al.   HEALTH AFFAIRS

How expensive is inflammatory bowel disease? A critical analysis

(2008) Selwyn Odes   WORLD JOURNAL OF GASTROENTEROLOGY